# Bioluminescence & marine fluorescent proteins
Engineered luciferases and fluorescent proteins derived from jellyfish, deep-sea shrimp and other marine organisms, redesigned via directed evolution and computational protein design into ultra-bright, photostable research tools for drug screening, cell imaging and protein-protein interaction detection.
Source: https://en.bioecon.ru/technology/bioluminescence-marine-fluorescent-proteins/
Updated: 2026-08-18
## Overview and value chain
Markers: [EC: Blue biotechnology & European Research Council fluorescence-imaging funding | OECD: Novel biomarker platforms & bio-imaging | Regulator: FDA (US imaging agents), EMA (EU diagnostics), NMPA (China)]
Bioluminescence and marine fluorescent proteins supply the core molecular toolkit for visualizing biological processes in real time, built on two distinct optical mechanisms: bioluminescence (enzymatic luciferin oxidation by luciferase, emitting light with no external excitation needed) and fluorescence (a protein absorbing light at one wavelength and re-emitting it at a longer wavelength, requiring laser or UV excitation). Promega's NanoLuc platform, an ultra-bright luciferase computationally optimized from a deep-sea shrimp enzyme, continues to anchor new research: a July 2025 study used NanoBiT and NanoBRET tags integrated at endogenous gene loci (EGFR/GRB2, KRas/CRAF) to build regulated protein-protein-interaction reporter cell lines for cancer research, while a January 2026 paper engineered GFP-NanoLuc fusion substrates for sensitive bioluminescence resonance energy transfer (BRET)-based protease-activity detection. Thermo Fisher's Molecular Probes portfolio remains central to fluorescent-protein innovation: a June 2026 study engineered a photoconvertible fluorescent protein incorporating the noncanonical amino acid p-borono-L-phenylalanine into circularly permuted mEos2 to create a peroxynitrite-responsive sensor, while another June 2026 paper introduced OCaMP, an orange fluorescent genetically encoded calcium indicator with improved two-photon imaging performance for neural-activity studies. ChromoTek (part of Proteintech) continues to expand its nanobody-based affinity toolkit beyond its original GFP-Trap, launching further development of its Spot-Tag system — a compact 12-amino-acid peptide tag paired with a high-affinity Spot-Nanobody — as of an April 2026 product update. In China, a Westlake University team led by Xin Zhang published a major breakthrough in Cell in November 2025, developing a new class of time-resolved fluorescent proteins (tr-FPs) that overcome prior limitations by engineering and regulating fluorescence-lifetime mechanisms, enabling multiplexed imaging distinguished by both color and excited-state lifetime — research supported by multiple National Natural Science Foundation of China grants.
The key directions of bioluminescence and marine fluorescent proteins are:
1. **Engineered ultra-bright luciferases:** computationally redesigned luciferase enzymes (such as NanoLuc, derived from deep-sea shrimp) delivering far higher signal intensity than classical firefly luciferase for drug-screening assays.
2. **Monomeric fluorescent protein engineering:** directed evolution and computational design of jellyfish- and coral-derived fluorescent proteins to eliminate oligomerization, increase brightness and shift emission spectra across the full visible-to-near-infrared range.
3. **Nanobody-based affinity purification:** single-domain llama antibody (VHH) fragments engineered for picomolar-affinity binding to fluorescent-protein tags, enabling ultra-clean immunoprecipitation without classical antibody contamination.
4. **Bioluminescence resonance energy transfer (BRET):** fusing a luciferase and a fluorescent protein into one construct so luciferin oxidation transfers energy non-radiatively to the fluorophore, creating an ultra-sensitive proximity sensor without external cell illumination.
### Sectoral value chain
```
[Sourcing from bioluminescent/fluorescent marine organisms] ──> [Directed evolution / computational protein design] ──> [Strain development (E. coli/yeast)]
│
(Fermentation & downstream purification)
│
[Commercial research reagents & screening kits] <──── [Formulation & assembly into diagnostic kits] <──────────────────────┘
```
### Value chain levels
| Level | Description | Key inputs/outputs |
|:---|:---|:---|
| **Sourcing** | Extracting RNA/cDNA from bioluminescent marine organisms (jellyfish, hydroids, copepods, deep-sea fish and bacteria). | **In:** Live marine organisms, cryogenic containers.
**Out:** Isolated total RNA, cDNA libraries. |
| **Protein design** | Computational modeling and directed evolution to eliminate oligomerization tendency, boost brightness and shift spectra. | **In:** Fold-design algorithms, error-prone DNA polymerases.
**Out:** Plasmids carrying optimized monomer genes. |
| **Strain development** | Transforming industrial E. coli or S. cerevisiae strains for high-yield fluorophore synthesis. | **In:** Competent cells, plasmid expression vectors.
**Out:** High-productivity recombinant producer clones. |
| **Fermentation** | Scaled fermentation under controlled conditions with induction optimized for maximum soluble chromophore accumulation. | **In:** Growth media, fermenters, inducers (IPTG).
**Out:** Brightly glowing deep-green/red cell paste. |
| **Downstream processing** | Cell disruption, centrifugation, extraction and chromatographic purification on hydrophobic and ion-exchange resins. | **In:** Cell paste, low-pressure chromatography systems, resins.
**Out:** High-purity recombinant protein (>98%). |
| **Formulation and assembly** | Packaging fluorescent proteins, freeze-drying or assembling into diagnostic kits and high-throughput screening systems. | **In:** Purified protein, buffers, PCR plates, antibodies.
**Out:** Commercial molecular-weight markers, reporter assay kits. |
Cross-cutting technologies of the sector:
- **Quantum-chemical chromophore design:** computational modeling of electron-density distribution in the chromophore's conjugated pi-system as influenced by surrounding amino acid residues, letting researchers precisely calculate mutations for a target absorption and emission spectrum.
- **Single-domain nanobody affinity reagents (e.g., GFP-Trap):** llama-derived single-domain antibody (VHH) fragments with picomolar affinity for GFP, enabling instant, high-purity pulldown of fusion-protein complexes from cell lysates for mass-spectrometry analysis.
- **Bioluminescence resonance energy transfer (BRET):** integrating a luciferase and fluorescent protein into one construct so luciferin oxidation transfers energy non-radiatively to the fluorophore, used as an ultra-sensitive sensor of molecular proximity without external cell illumination.
---
## US
The United States leads development of bioluminescent reporter systems for pharmaceutical screening and remains the primary source of advanced fluorescent-protein reagent catalogs.
### Promega's NanoLuc/NanoBRET research pipeline, Thermo Fisher's photoconvertible and calcium-indicator innovations, NIH high-throughput screening
- **Promega Corporation:** its NanoLuc luciferase platform continues to anchor new research, including a July 2025 study using NanoBiT/NanoBRET tags at endogenous gene loci for cancer protein-protein-interaction reporter cell lines, and a January 2026 paper engineering GFP-NanoLuc BRET fusion substrates for protease-activity detection.
- **Thermo Fisher Scientific (Molecular Probes):** a June 2026 study engineered a photoconvertible fluorescent protein incorporating a noncanonical amino acid into circularly permuted mEos2 to create a peroxynitrite-responsive sensor, while another June 2026 paper introduced OCaMP, an improved orange fluorescent calcium indicator for neural-activity imaging.
- **NIH high-throughput screening:** continues to fund robotic screening systems using fluorescent and bioluminescent sensors to test chemical libraries against cancer and neurodegenerative disease targets across millions of compounds.
---
## CN
China is building fundamental fluorescent-protein research capability alongside its established bio-imaging equipment manufacturing base.
### Westlake University's time-resolved fluorescent protein breakthrough, Suzhou bio-imaging equipment cluster, aquaculture Lux-biosensors
- **Westlake University:** a team led by Xin Zhang published a major breakthrough in Cell in November 2025, developing a new class of time-resolved fluorescent proteins (tr-FPs) that overcome prior spectral-crowding limitations by engineering and regulating fluorescence-lifetime mechanisms, enabling multiplexed imaging distinguished by both color and excited-state lifetime.
- **Suzhou bio-imaging cluster:** the Suzhou Industrial Park has become a center for Chinese optical instrument manufacturing, hosting factories producing laser-scanning confocal microscopes, flow cytometers and macro-imagers for bioluminescent reporter animals, increasingly substituting for expensive American and Japanese equipment.
- **Aquaculture biosensors:** China is deploying recombinant bacteria with embedded bioluminescent Lux operons to detect trace heavy metals, antibiotics and pesticides in South China Sea coastal waters, with sensor-bacteria luminescence dimming in the presence of contaminants for instant environmental-threat detection.
---
## EU
The European Union holds strong positions in engineering next-generation monomeric fluorescent proteins and the nanobody-based reagents built on them.
### ChromoTek/Proteintech's expanding nanobody toolkit, Horizon Europe bio-sensing funding, European fluorescent-protein patent licensing
- **ChromoTek (part of Proteintech):** continues to expand its nanobody-based affinity toolkit beyond its original GFP-Trap and RFP-Trap products, with an April 2026 update detailing further development of its Spot-Tag system — a compact 12-amino-acid peptide tag paired with a high-affinity Spot-Nanobody for antibody-free immunoprecipitation.
- **Horizon Europe bio-sensing funding:** the European Commission continues to fund multi-million-euro grants to consortia developing wearable and implantable fluorescent sensors for continuous glucose, lactate and blood-gas monitoring, combining optical-protein developers with microfluidic sensor-system engineers.
- **European fluorescent-protein patent licensing:** European-discovered second-generation monomeric fluorescent proteins (bright variants derived from sea anemones, hydroid polyps and copepods) remain widely licensed to major transnational reagent suppliers, anchoring the region's position in fluorophore intellectual property.
---
## Leading companies and research institutes
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|:---|:---|:---|:---|:---|
| **Promega Corporation** | 🇺🇸 USA | *NanoLuc*, *NanoBiT*, *NanoBRET* | Ultra-bright luciferase, endogenous-locus PPI reporters | commercial |
| **Thermo Fisher Scientific** | 🇺🇸 USA | *Molecular Probes* portfolio | Photoconvertible sensors, genetically encoded calcium indicators | commercial |
| **ChromoTek (Proteintech)** | 🇩🇪 Germany | *GFP-Trap*, *RFP-Trap*, *Spot-Tag* | Nanobody-based affinity purification, antibody-free IP | commercial |
| **Westlake University** | 🇨🇳 China | Time-resolved fluorescent proteins (tr-FPs) | Fluorescence-lifetime engineering for multiplexed imaging | research |
---
## Tech stack and innovations
The bioluminescence and marine-fluorescent-protein stack combines advanced optical instrumentation with cell-free and computational protein engineering:
1. **Fluorescence lifetime imaging microscopy (FLIM):**
- Advanced laser-scanning systems measure not just fluorophore emission intensity but the nanosecond-scale lifetime of its excited state, letting researchers measure local viscosity, pH and polarity inside a cell independent of overall fluorescent-protein concentration.
2. **Multi-detector high-throughput microplate readers:**
- Robotic analyzers equipped with laser diodes and ultra-sensitive photomultiplier tubes simultaneously read FRET, BRET and fluorescence-polarization signals in 384- and 1536-well plate formats at sub-picogram sensitivity.
3. **Cell-free protein synthesis systems:**
- Reactor modules using E. coli or wheat-germ lysates assemble and fold fluorescent proteins in vitro, enabling rapid production of labeled toxic proteins whose expression would otherwise kill the living host cell during standard fermentation.
---
## Value chains and production pipelines
### Industrial pipeline for producing high-purity recombinant green fluorescent protein (rGFP) for cell microscopy and calibration (ISO 9001/research grade)
```
┌───────────────────────────┐ ┌───────────────────────────┐
│ 1. Gene optimization & │ ───> │ 2. Expression in E. coli │
│ plasmid cloning │ │ (IPTG induction, 37°C) │
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 4. Ammonium sulfate │ <─── │ 3. Cell disruption & │
│ fractionation │ │ ultracentrifugation │
└───────────────────────────┘ └───────────────────────────┘
│
▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ 5. Hydrophobic & metal- │ ───> │ 6. Freeze-drying & │
│ affinity chromatography │ │ spectral QC │
└───────────────────────────┘ └───────────────────────────┘
```
#### Stage 1: Optimized rGFP gene design and plasmid construction
Bioinformatic analysis of wild-type green fluorescent protein structure guides directed mutagenesis introducing point substitutions (such as S65T and F64L) that sharply increase fluorescence brightness and accelerate chromophore maturation; the codon-optimized gene is chemically synthesized, cloned into a pET-28a plasmid vector under a T7 promoter, with an N-terminal hexahistidine tag added for purification.
#### Stage 2: Transformation and bioreactor fermentation
The plasmid transforms competent E. coli BL21(DE3) cells; a single colony seeds an LB culture, which is transferred to a 500 L industrial fermenter with glucose-based synthetic media at 37°C; upon reaching OD600 ≈ 6.0, IPTG inducer is added to 0.5 mM and temperature drops to 30°C to reduce inclusion-body formation, with induction continuing for 6 hours before harvest as an emerald-green cell paste.
#### Stage 3: Cell disruption and extract clarification
Cell paste is suspended in lysis buffer with lysozyme, then continuously pumped through an ultrasonic flow disruptor under ice-bath cooling until over 95% cell lysis is confirmed microscopically; the disrupted mass is ultracentrifuged at 30,000g for 40 minutes to separate cell debris, and the glowing supernatant is decanted.
#### Stage 4: Primary ammonium sulfate protein fractionation
Solid ammonium sulfate is added to the clarified supernatant to 40% saturation, precipitating host ballast proteins while hydrophilic GFP remains in solution; after removing this precipitate, further ammonium sulfate is added to 75% saturation to precipitate rGFP, which is collected by centrifugation and redissolved in a minimal buffer volume.
#### Stage 5: Two-stage chromatographic purification (IMAC and HIC)
The redissolved concentrate is desalted by gel filtration, then loaded onto a nickel-affinity (Ni-NTA) column where the His-tagged rGFP binds while ballast proteins wash out and is eluted with high-imidazole buffer; a second hydrophobic-interaction chromatography step (Butyl Sepharose) under high ammonium sulfate further purifies the protein via descending salt gradient, with pure fractions pooled and concentrated by ultrafiltration.
#### Stage 6: Freeze-drying, final formulation and spectral quality control
The purified protein solution is dialyzed against deionized water with mannitol cryoprotectant, sterile-filtered, filled into glass vials and freeze-dried under deep vacuum, sealed under argon; quality control confirms >99% purity by SDS-PAGE, absorption/emission maxima at 488/509 nm by spectrophotometry, and absence of nuclease/protease contamination before certification as a calibration standard for research institutes.